CETT Pilot Program Under Evaluation
The CETT Pilot Program is no longer accepting applications for genetic test development. An evaluation of the Pilot Program is ongoing and future program activities will be determined when the evaluation has been completed. Considerable experience has been gained in the translation of research discoveries to genetic tests and the development of educational materials for health care providers, patients and families. The evaluation of the program should be completed before December 2010 and additional information will be provided on the website at that time. In addition, applicants should not upload any information in CETTrack. We are sorry about the inconvenience.
|
![](images/green_box_top_left.gif)
|
![](images/green_box_top_right.gif)
|
Focus on Data Collection and Patient Privacy
The collection of important clinical and genetic information is part of the routine testing process. The CETT Program has created documents and answers to frequently asked questions (FAQs) that detail the specific policies and safeguards used by CETT Program participants to maximize the benefit of these data while protecting patient privacy.
One of the key goals of the CETT Program is increasing research opportunities for rare diseases. Research can produce breakthroughs in treatment and management of these conditions. It also may lead to improved treatment and care of other common health conditions. Research opportunities are created by protecting patient confidentiality and making the information freely available to the research community. Keeping de-identified clinical data in public databases for research purposes is a groundbreaking approach. To see the privacy protection policies created by the CETT Program click
Focus on Researchers
Researchers play a key role in the CETT Programs goal to facilitate the translation of new tests for rare genetic diseases by providing assistance in the test design and translation process. After test development, researchers provide consultation to the clinical laboratory as new gene variants are identified and classified. Researchers also work with the clinical laboratory, clinicians and patient advocacy members to develop and update educational materials.
|
![](images/green_box_bottom_left.gif)
|
![](images/green_box_bottom_right.gif)
|
|